Oragenics Statistics
Total Valuation
Oragenics has a market cap or net worth of $3.35 million. The enterprise value is $2.31 million.
Important Dates
The last earnings date was Wednesday, November 13, 2024.
| Earnings Date | Nov 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Oragenics has 12.21 million shares outstanding. The number of shares has increased by 99.08% in one year.
| Current Share Class | 12.21M |
| Shares Outstanding | 12.21M |
| Shares Change (YoY) | +99.08% |
| Shares Change (QoQ) | +44.14% |
| Owned by Insiders (%) | 5.91% |
| Owned by Institutions (%) | 5.15% |
| Float | 7.32M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.73 |
| P/TBV Ratio | 2.25 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.93, with a Debt / Equity ratio of 0.17.
| Current Ratio | 1.93 |
| Quick Ratio | 1.48 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -643.28 |
Financial Efficiency
Return on equity (ROE) is -417.05% and return on invested capital (ROIC) is -235.58%.
| Return on Equity (ROE) | -417.05% |
| Return on Assets (ROA) | -190.79% |
| Return on Capital (ROIC) | -235.58% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.99M |
| Employee Count | 5 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -92.17% in the last 52 weeks. The beta is 0.48, so Oragenics's price volatility has been lower than the market average.
| Beta (5Y) | 0.48 |
| 52-Week Price Change | -92.17% |
| 50-Day Moving Average | 0.36 |
| 200-Day Moving Average | 1.20 |
| Relative Strength Index (RSI) | 35.60 |
| Average Volume (20 Days) | 643,376 |
Short Selling Information
The latest short interest is 191,085, so 1.56% of the outstanding shares have been sold short.
| Short Interest | 191,085 |
| Short Previous Month | 117,606 |
| Short % of Shares Out | 1.56% |
| Short % of Float | 2.61% |
| Short Ratio (days to cover) | 0.43 |
Income Statement
| Revenue | n/a |
| Gross Profit | -15.49M |
| Operating Income | -20.00M |
| Pretax Income | -19.52M |
| Net Income | -19.97M |
| EBITDA | -19.98M |
| EBIT | -20.00M |
| Earnings Per Share (EPS) | -$4.66 |
Full Income StatementBalance Sheet
The company has $3.14 million in cash and $519,392 in debt, giving a net cash position of $2.62 million or $0.21 per share.
| Cash & Cash Equivalents | 3.14M |
| Total Debt | 519,392 |
| Net Cash | 2.62M |
| Net Cash Per Share | $0.21 |
| Equity (Book Value) | 3.08M |
| Book Value Per Share | 0.16 |
| Working Capital | 1.99M |
Full Balance SheetCash Flow
| Operating Cash Flow | -7.68M |
| Capital Expenditures | n/a |
| Free Cash Flow | -7.68M |
| FCF Per Share | -$0.63 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -95,775.77% |